On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


National Storm Recovery Inc. (NSRI) Ready for Record-Breaking Hurricane Season

  • Preparing for a record-breaking active hurricane season in Florida
  • Working to stop the destructive cycle of storm waste in landfills and disposal sites
  • Starting storm season in solid position with recent acquisition, three long-term contracts already in place

While the majority of companies have their eyes on COVID-19 and what recovery from “stay-at-home” orders look like, National Storm Recovery Inc. (OTC: NSRI) is preparing for what looks to be an active hurricane season in Florida.

April 2020 set heat records across the world. According to the National Oceanic and Atmospheric Administration (NOAA), 2020 is set to be earth’s warmest year on record while the European Union’s Copernicus Climate Change Service predicts it will rank as one of the top two (http://ibn.fm/cmj5I). Florida was no exception setting with high-temp records set across the state. Typically, higher temps forecast an active hurricane season as heat and warm ocean water play vital roles in powering the storms. The NOAA has reported that the strip of ocean where hurricanes begin was a full 1.1 degrees Celsius warmer than average.

How does all of this effect hurricane season? An article in the Miami Herald (http://ibn.fm/tMeUZ) quoted Michael Mann, director of the Earth System Science Center at Pennsylvania State University, who stated, “We have these bathtub-like conditions of extreme warmth combined with a La Nina-like state of the climate system. In our statistical model, it’s the same sort of condition we saw in 2005.” The center is predicting anywhere from 15 to 24 hurricanes, with 20 named storms in 2020. In 2005, the United States experienced five hurricanes that made landfall, one of which was Katrina.

Historically storm-waste disposal has created an environmental burden on landfills and disposal sites around the nation, only adding to the problem of climate change and the conditions that create these destructive storms. National Storm Recovery, headquartered in Florida, has created a synergistic and environmentally beneficial solution to stop the cycle. The company collects tree debris that is then processed for recycling and manufacturing into organic, next-generation mulch products that are sold to retailers, landscapers, installers and garden centers.

NSRI is used to weathering storms, and as the company prepares for the upcoming hurricane season, it does so in a solid position. The company recently acquired Mulch Manufacturing and has three long-term contracts already in place: a three-year agreement with one of the largest waste disposal companies to lease their yard waste facility; a three-year contract with two one-year renewals for emergency debris and tree removal services for the town of Oakland, Florida; and a three-year contract with two one-year renewals for tree trimming and removal services for Orange County [Florida] Public Schools (http://ibn.fm/Ie3Yf).

NSRI has proved to be a formidable force amid the storms the United States is facing. Whether those storms are founded in economics or Mother Nature, NSRI has a firm foundation and is standing ready to make a difference for customers, employees and shareholders.

For more information, visit the company’s website at www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

From Our Blog

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Mines Investment-building Opportunity for Brain Tumor-Targeting Drug Candidate at Annual Conference

September 23, 2020

CNS Pharmaceuticals is a clinical-stage biotechnology company developing therapies to combat aggressive cancers of the brain and central nervous system The company will be applying for approval to launch Phase II trials in the first quarter of 2021 for its leading drug candidate, Berubicin, which targets glioblastoma multiforme (“GBM”) brain cancer CNS Pharmaceuticals CEO addressed […]

Rotate your device 90° to view site.